WSB1 Degrader 1
CAS No. 2306039-66-5
WSB1 Degrader 1 ( —— )
产品货号. M24048 CAS No. 2306039-66-5
WSB1 Degrader 1 是一种有效的口服活性 WD 重复序列和包含 1 个 SOCS 盒的降解剂。 WSB1 Degrader 1 具有抗癌转移作用。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2001 | 有现货 |
|
10MG | ¥3183 | 有现货 |
|
25MG | ¥5330 | 有现货 |
|
50MG | ¥7590 | 有现货 |
|
100MG | ¥10287 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称WSB1 Degrader 1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述WSB1 Degrader 1 是一种有效的口服活性 WD 重复序列和包含 1 个 SOCS 盒的降解剂。 WSB1 Degrader 1 具有抗癌转移作用。
-
产品描述WSB1 Degrader 1 is a poten and orally active?WD repeat and SOCS box-containing 1 degrader. WSB1 Degrader 1 has anticancer metastatic effects.
-
体外实验WSB1 Degrader 1 (compound 4; 0.25-2500 nM; 2-24 hours; H1299-WSB1 cells) treatment indues WSB1 degradation in time-dependent and dose-dependent manners.WSB1 Degrader 1 (compound 4) exhibits potent antimigration efficacy in both KHOS and H460 cell lines with IC50 values of 39.1 μM and 24.47 μM, respectively.WSB1 Degrader 1 (compound 4) significantly inhibits cancer cell migration under normoxia and hypoxia in KHOS cells. WSB1 Degrader 1 (5 μM) treatment elevates the levels of the RhoGDI2 protein in KHOS cells under hypoxia.The wound-healing of H1299-WSB1 cells is significantly inhibited by treating with WSB1 Degrader 1. WSB1 Degrader 1 can only block the wound-healing capability of wild-type A2780 (A2780-WT) cells but not the A2780-WSB1/KO cells. Western Blot Analysis Cell Line:H1299-WSB1 cells Concentration:0.25 nM, 2.5 nM, 25 nM, 250 nM, 2500 nM Incubation Time:2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 24 hours Result:Induced WSB1 degradation in time-dependent and dose-dependent manners.
-
体内实验WSB1 Degrader 1 (compound 4; 100 mg/kg; p.o.; daily; for 28 days) treatment can effectively inhibit the pulmonary metastasis of cancer cells.In rats, after 100 mg/kg oral dosing or 160 mg/kg intraperitoneal dosing of WSB1 Degrader 1 (compound 4), the two ways of administration are observed with quick absorption (Tmax), but the former dosing displayed a fast clearance (T1/2). Moreover, Cmax and AUC0-t values of WSB1 Degrader 1 in oral or intraperitoneal dosing groups showed acceptable blood exposure. Animal Model:Balb/c (nu/nu) mice bearing highly metastatic 4T1 breast cancer cells.Dosage:100 mg/kg/day.Administration:p.o.; daily; for 28 days Result:Effectively inhibited the pulmonary metastasis of cancer cells.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体WSB1
-
研究领域——
-
适应症——
化学信息
-
CAS Number2306039-66-5
-
分子量334.41
-
分子式C21H22N2O2
-
纯度>98% (HPLC)
-
溶解度DMSO:24 mg/mL?(71.76 mM;?Need ultrasonic)
-
SMILESNC1=NC(C2=CC=C(OC)C(C)=C2)=C(C3=CC=C(OC)C(C)=C3)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Jinxin Che, et al. Discovery of 5,6-Bis(4-methoxy-3-methylphenyl)pyridin-2-amine as a WSB1 Degrader to Inhibit Cancer Cell Metastasis. J Med Chem. 2021 Jun 1.